Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
36696220 | 0 | Choi SJ, Dwyer CN, Rapkin L, et al. The mechanistic and structural role of von Willebrand factor in endotoxemia-enhanced deep vein thrombosis in mice. J Thromb Haemost. 2022 Dec 22:S1538-7836(22)07636-X. doi: 10.1016/j.jtha.2022.11.022. | |
35780487 | 0 | Lavin M, Christopherson P, Grabell J, et al. Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding score. J Thromb Haemost. 2022 Jul 3. doi: 10.1111/jth.15807. | |
35445575 | 0 | Lillicrap D, Morrissey JH. Investment in the future of thrombosis and hemostasis science. J Thromb Haemost. 2022 May;20(5):1033. doi: 10.1111/jth.15710. | |
35028601 | 0 | Michels A, Lillicrap D, Yacob M. Role of von Willebrand factor in venous thromboembolic disease. JVS Vasc Sci. 2021 Oct 7;3:17-29. doi: 10.1016/j.jvssci.2021.08.002. eCollection 2022. | |
34649864 | 0 | Sholzberg M, Tang GH, Rahhal H, et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ. 2021 Oct 14;375:n2400. doi: 10.1136/bmj.n2400. | |
34351057 | 0 | Othman M, Baker AT, Gupalo E, et al. To clot or not to clot? Ad is the question-Insights on mechanisms related to vaccine-induced thrombotic thrombocytopenia. J Thromb Haemost. 2021 Nov;19(11):2845-2856. doi: 10.1111/jth.15485. Epub 2021 Aug 23. | |
34327823 | 0 | Lillicrap D, Morrissey JH. Evidence-based medicine in thrombosis and hemostasis: ISTH to the fore. J Thromb Haemost. 2021 Aug;19(8):1845-1846. doi: 10.1111/jth.15436. | |
34288447 | 0 | Batty P, Lillicrap D. Gene therapy for hemophilia: Current status and laboratory consequences. Int J Lab Hematol. 2021 Jul;43 Suppl 1:117-123. doi: 10.1111/ijlh.13605. | |
34152080 | 0 | Michels A, Swystun LL, Dwyer CN, et al. Stabilin-2 deficiency increases thrombotic burden and alters the composition of venous thrombi in a mouse model. J Thromb Haemost. 2021 Oct;19(10):2440-2453. doi: 10.1111/jth.15429. Epub 2021 Jul 19. | |
33691765 | 0 | Sholzberg M, Tang GH, Negri E, et al. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0. | |
33506480 | 0 | Blanchette VS, Zunino L, Grassmann V, et al. A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects. Thromb Haemost. 2021 Oct;121(10):1326-1336. doi: 10.1055/a-1376-0970. Epub 2021 Jan 27. | |
33410894 | 0 | Abrams ST, Su D, Sahraoui Y, et al. Assembly of alternative prothrombinase by extracellular histones initiates and disseminates intravascular coagulation. Blood. 2021 Jan 7;137(1):103-114. doi: 10.1182/blood.2019002973. | |
33170819 | 0 | Lillicrap D. Evaluating the potential benefits of the extravascular pool of factor IX. Blood Coagul Fibrinolysis. 2021 Jan 1;32(1):68-69. doi: 10.1097/MBC.0000000000000969. | |
32967458 | 0 | Michels A, Dwyer CN, Mewburn J, et al. von Willebrand Factor Is a Critical Mediator of Deep Vein Thrombosis in a Mouse Model of Diet-Induced Obesity. Arterioscler Thromb Vasc Biol. 2020 Dec;40(12):2860-2874. doi: 10.1161/ATVBAHA.120.314690. Epub 2020 Sep 24. | |
32881334 | 0 | Lillicrap D, Morrissey JH. 2020 - Year of COVID-19. J Thromb Haemost. 2020 Sep;18(9):2081. doi: 10.1111/jth.15041. | |
31999061 | 0 | Lillicrap D, Morrissey JH. Hemostasis and thrombosis 101-A challenge to energize. J Thromb Haemost. 2020 Feb;18(2):269. doi: 10.1111/jth.14731. | |
31479183 | 0 | Lillicrap D, Morrissey JH. Genomic momentum for hemostasis and thrombosis. J Thromb Haemost. 2019 Sep;17(9):1411. doi: 10.1111/jth.14582. | |
31404933 | 0 | Ghorbanpour E, Lillicrap D. Innovative Molecular Testing Strategies for Adjunctive Investigations in Hemostasis and Thrombosis. Semin Thromb Hemost. 2019 Oct;45(7):751-756. doi: 10.1055/s-0039-1692977. Epub 2019 Aug 12. | |
31350267 | 0 | Swystun LL, Ogiwara K, Rawley O, et al. Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients. Blood. 2019 Sep 12;134(11):880-891. doi: 10.1182/blood.2019000190. Epub 2019 Jul 26. | |
31152504 | 0 | Lillicrap D, Morrissey JH. 27th ISTH Congress - July in Melbourne. J Thromb Haemost. 2019 Jun;17(6):847. doi: 10.1111/jth.14463. | |
31011709 | 0 | Shida Y, Swystun LL, Brown C, et al. Shear stress and platelet-induced tensile forces regulate ADAMTS13-localization within the platelet thrombus. Res Pract Thromb Haemost. 2019 Mar 23;3(2):254-260. doi: 10.1002/rth2.12196. eCollection 2019 Apr. | |
30046746 | 0 | Bergmeier W, Antoniak S, Conway EM, et al. Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis. Res Pract Thromb Haemost. 2018 Apr 12;2(3):407-428. doi: 10.1002/rth2.12095. eCollection 2018 Jul. | |
28829426 | 0 | Michels A, Swystun LL, Mewburn J, et al. Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation. J Vis Exp. 2017 Aug 14;(126). doi: 10.3791/55917. | |
28808146 | 0 | Lillicrap D. Thrombolytic Potential of N-Acetylcysteine: Evidence for Significant Benefit in Mitigating Arterial Thrombosis. Circulation. 2017 Aug 15;136(7):661-663. doi: 10.1161/CIRCULATIONAHA.117.029313. | |
26862110 | 0 | Flood VH, Christopherson PA, Gill JC, et al. Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States. Blood. 2016 May 19;127(20):2481-8. doi: 10.1182/blood-2015-10-673681. Epub 2016 Feb 9. | |
26149009 | 0 | Lillicrap D, Douketis J. Journal of Thrombosis and Haemostasis. Special Issue: State of the Art 2015. Preface. J Thromb Haemost. 2015 Jun;13 Suppl 1:S1. doi: 10.1111/jth.12979. |